TY  - GEN
AU  - Moore,A M
AU  - Einhorn,L H
AU  - Estes,D
AU  - Govindan,R
AU  - Axelson,J
AU  - Vinson,J
AU  - Breen,T E
AU  - Yu,M
AU  - Hanna,N H
TI  - Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial
SN  - 0169-5002
PY  - 2006///0921
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - therapeutic use
KW  - Carcinoma, Small Cell
KW  - drug therapy
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gefitinib
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Quinazolines
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.lungcan.2005.12.002
ER  -